APR-1051
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for APR-1051, covering 2026-04-23 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Study of APR-1051 in Patients With Advanced Solid Tumors [Phase 1]